Dr. Koob is the Chief Scientific Officer of MiMedx. He is the senior executive responsible for the overall research direction and oversight of the Company’s product and tissue offerings. Dr. Koob is the inventor on the patents related to the Company’s CollaFix™ technology that are the basis of the Company’s license agreement with Shriners Hospitals for Children and the University of South Florida. MiMedx was founded around the collagen technology developed by Dr. Koob.
Prior to MiMedx, Dr. Koob was Section Chief of Skeletal Biology at Shriners Hospital for Children in Tampa, Florida. During the fourteen years he held this position, Dr. Koob developed and patented the core technology for what would become the MiMedx CollaFix™ technology platform. Prior to his tenure with Shriners, Dr. Koob held various research appointments at institutions such as the Department of Biology at Boston University, Department of Biological Chemistry at Harvard Medical School, Department of Biology at the University of New Mexico, Department of Anatomy at the University of New Mexico School of Medicine, Orthopaedic Biomechanics Laboratory at Beth Israel Hospital, and Mount Desert Island Biological Laboratory.
Dr. Koob has published over 125 biomedical and biological articles and 12 book chapters, and he is listed as an inventor on over 40 issued and pending patents.
Dr. Koob received his Ph.D. in Biochemistry from Washington University School of Medicine in St. Louis, Missouri. He completed four years of post-doctoral training at Harvard Medical School and four years of specialty training in the Laboratory of Skeletal Disorders, Department of Orthopaedics at Children’s Hospital Medical Center in Boston.